Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1135)
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.08
Total Value
$123.20K
Shares Held After
883,735
% of Holdings
4.3%
VERACYTE, INC. (VCYT)
Wygant Jonathan — VP, Chief Accounting Officer
Shares
24,000
Price
$45.40
Total Value
$1.09M
Shares Held After
45,434
% of Holdings
34.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,478
Price
$26.00
Total Value
$64.43K
Shares Held After
28,523
% of Holdings
8.0%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
4,504
Price
$26.00
Total Value
$117.10K
Shares Held After
376,569
% of Holdings
1.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
1,165
Price
$5.69
Total Value
$6.63K
Shares Held After
194,924
% of Holdings
0.6%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,685
Price
$26.78
Total Value
$71.92K
Shares Held After
147,499
% of Holdings
1.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
10,926
Price
$26.78
Total Value
$292.65K
Shares Held After
479,989
% of Holdings
2.2%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,489
Price
$26.78
Total Value
$39.88K
Shares Held After
21,661
% of Holdings
6.4%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,861
Price
$26.78
Total Value
$49.85K
Shares Held After
55,780
% of Holdings
3.2%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
2,358
Price
$26.78
Total Value
$63.16K
Shares Held After
228,759
% of Holdings
1.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,176
Price
$19.00
Total Value
$41.34K
Shares Held After
62,371
% of Holdings
3.4%
Pelthos Therapeutics Inc. (PTHS)
Francis Knuettel II — CFO, Treas & Secty
Shares
1,500
Price
$26.84
Total Value
$40.26K
Shares Held After
11,316
% of Holdings
11.7%
Ainos, Inc. (AIMD)
lee ting-chuan — Director
Shares
9,302
Price
$1.57
Total Value
$14.60K
Shares Held After
917,405
% of Holdings
1.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
87,425
Price
$0.45
Total Value
$39.34K
Shares Held After
831,635
% of Holdings
9.5%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.52
Total Value
$1.54M
Shares Held After
1,073,095
% of Holdings
2.3%
Pharvaris N.V. (PHVS)
Nijdam Anna — Principal Accounting Officer
Shares
5,501
Price
$30.74
Total Value
$169.08K
Shares Held After
48,945
% of Holdings
10.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$569.73
Total Value
$91.16K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,181
Price
$568.86
Total Value
$671.82K
Shares Held After
40,673
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,407
Price
$568.00
Total Value
$2.50M
Shares Held After
41,854
% of Holdings
9.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,210
Price
$567.30
Total Value
$1.82M
Shares Held After
46,261
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
382
Price
$565.77
Total Value
$216.12K
Shares Held After
49,471
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$564.66
Total Value
$63.81K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
47
Price
$563.27
Total Value
$26.47K
Shares Held After
49,966
% of Holdings
0.1%
Vaxart, Inc. (VXRT)
Watson W. Mark — Director
Shares
10,000
Price
$0.65
Total Value
$6.53K
Shares Held After
134,125
% of Holdings
7.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
307
Price
$8.33
Total Value
$2.56K
Shares Held After
50,704
% of Holdings
0.6%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.93
Total Value
$19.30K
Shares Held After
20,000
% of Holdings
50.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$9.81
Total Value
$981.30K
Shares Held After
836,000
% of Holdings
12.0%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$30.27
Total Value
$6.05M
Shares Held After
1,613,063
% of Holdings
11.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
80
Price
$519.98
Total Value
$41.60K
Shares Held After
22,015
% of Holdings
0.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
782
Price
$518.76
Total Value
$405.67K
Shares Held After
22,095
% of Holdings
3.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
1,497
Price
$517.59
Total Value
$774.84K
Shares Held After
22,877
% of Holdings
6.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
723
Price
$516.87
Total Value
$373.69K
Shares Held After
24,374
% of Holdings
2.9%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
657
Price
$515.92
Total Value
$338.96K
Shares Held After
25,097
% of Holdings
2.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
343
Price
$514.67
Total Value
$176.53K
Shares Held After
25,754
% of Holdings
1.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
40
Price
$512.97
Total Value
$20.52K
Shares Held After
26,097
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
439
Price
$512.50
Total Value
$224.99K
Shares Held After
26,137
% of Holdings
1.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
610
Price
$511.40
Total Value
$311.95K
Shares Held After
26,576
% of Holdings
2.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
151
Price
$510.36
Total Value
$77.06K
Shares Held After
27,186
% of Holdings
0.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
320
Price
$508.24
Total Value
$162.64K
Shares Held After
27,337
% of Holdings
1.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
40
Price
$506.68
Total Value
$20.27K
Shares Held After
27,657
% of Holdings
0.1%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
6,500
Price
$5.46
Total Value
$35.46K
Shares Held After
77,565
% of Holdings
7.7%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
6,149
Price
$108.47
Total Value
$666.98K
Shares Held After
41,613
% of Holdings
12.9%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
3,420
Price
$1.04
Total Value
$3.56K
Shares Held After
18,874
% of Holdings
18.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
55,684
Price
$3.09
Total Value
$171.84K
Shares Held After
1,061,724
% of Holdings
5.0%
Ainos, Inc. (AIMD)
lee ting-chuan — Director
Shares
9,000
Price
$1.56
Total Value
$14.04K
Shares Held After
926,707
% of Holdings
1.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
36,387
Price
$0.42
Total Value
$15.28K
Shares Held After
919,060
% of Holdings
3.8%
Liquidia Corp (LQDA)
SINGH RAMAN — Director
Shares
29,494
Price
$60.13
Total Value
$1.77M
Shares Held After
38,755
% of Holdings
43.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.13
Total Value
$1.53M
Shares Held After
1,098,095
% of Holdings
2.2%
Pharvaris N.V. (PHVS)
Nijdam Anna — Principal Accounting Officer
Shares
1,829
Price
$30.60
Total Value
$55.97K
Shares Held After
48,945
% of Holdings
3.6%
Pharvaris N.V. (PHVS)
Nassif David W. — CFO / CLO
Shares
10,000
Price
$30.31
Total Value
$303.08K
Shares Held After
120,300
% of Holdings
7.7%
Showing 151–200 of 1135 transactions (page 4 of 23)